English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Eli Lilly And Company
Ruth de Jauregui
| Dec 4, 2016
Potential Alzheimer's drug fails to produce significant results
Ruth de Jauregui
| Dec 4, 2016
Bridging the gap between patients, researchers
Robert Hadley
| Dec 4, 2016
Patient advocacy, collaboration discussed at Brussels EFPIA meeting
Amanda Rupp
| Oct 16, 2016
Health experts recommend adjusting expectations related to Alzheimer’s treatment goal
Amanda Rupp
| Sep 18, 2016
Alzheimer’s Readiness Award granted to Boston mayor, local chapter of Alzheimer’s Association
Amanda Rupp
| Aug 19, 2016
Lilly announces new promotions, retiree
Amanda Rupp
| Jul 30, 2016
Potential connection found between Alzheimer’s progression, tau pathology
Amanda Rupp
| Jul 7, 2016
Jardiance limits kidney disease risk for type 2 diabetes patients with cardiovascular disease
Trending
Patient Daily
| Jul 8, 2025
Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+
Pharmaceuticals
Patient Daily
| Jul 10, 2025
PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
+
Pharmaceuticals
Patient Daily
| Jul 8, 2025
Psychedelic mushrooms' compound shows potential antiaging effects
Patient Daily
| Jul 9, 2025
FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment
« First
«
1
2
3